Detalles de la búsqueda
1.
Bleeding and thrombotic risk of different antiplatelet regimens posttranscatheter edge-to-edge mitral valve repair in patients with an indication for oral anticoagulation: Results from an all-comers national registry.
Catheter Cardiovasc Interv
; 103(2): 382-388, 2024 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38078877
2.
Percutaneous treatment of left circumflex coronary artery injury related to mitral valve surgery: Case series and systematic review of the literature.
Catheter Cardiovasc Interv
; 102(1): 121-137, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37210617
3.
Minimalistic hybrid approach for the percutaneous treatment of chronic coronary total occlusions: An in-depth analysis of the whole algorithm.
Catheter Cardiovasc Interv
; 100(4): 502-511, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35900200
4.
Efficacy of coronary sinus Reducer in patients with refractory angina and diabetes mellitus.
Heart Vessels
; 37(2): 194-199, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34374824
5.
A prospective evaluation of a redefined version of the "minimalistic hybrid approach" algorithm for percutaneous coronary chronic total occlusion revascularization.
Catheter Cardiovasc Interv
; 98(4): 617-625, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32755018
6.
BIOSOLVE-IV-registry: Safety and performance of the Magmaris scaffold: 12-month outcomes of the first cohort of 1,075 patients.
Catheter Cardiovasc Interv
; 98(1): E1-E8, 2021 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32881396
7.
Coronary sinus anatomical features: Description and procedural implications during coronary sinus Reducer implantation.
Catheter Cardiovasc Interv
; 97(7): E929-E935, 2021 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33211373
8.
Coronary Sinus Reducer for the Treatment of Chronic Refractory Angina: Will This Challenge the Treatment of Coronary Chronic Total Occlusions?
Curr Cardiol Rep
; 23(4): 31, 2021 03 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33655425
9.
The REMEDEE trial: 5-Year results on a novel combined sirolimus-eluting and endothelial progenitor cells capturing stent.
Catheter Cardiovasc Interv
; 95(6): 1076-1084, 2020 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31489742
10.
Incomplete coronary sinus reducer endothelialization as potential mechanism of clinical failure.
Catheter Cardiovasc Interv
; 94(1): 120-122, 2019 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30907065
11.
Is a covered stent justifiable in the treatment of coronary artery perforation? An observational analysis of long-term results of two different covered stent types.
Catheter Cardiovasc Interv
; 93(3): 419-425, 2019 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30280487
12.
Impact of coronary sinus reducer on absolute coronary blood flow and microvascular resistance.
Catheter Cardiovasc Interv
; 2024 May 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38716778
13.
Efficacy of a device to narrow the coronary sinus in refractory angina.
N Engl J Med
; 372(6): 519-27, 2015 Feb 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-25651246
14.
Safety and clinical performance of a drug eluting absorbable metal scaffold in the treatment of subjects with de novo lesions in native coronary arteries: Pooled 12-month outcomes of BIOSOLVE-II and BIOSOLVE-III.
Catheter Cardiovasc Interv
; 92(7): E502-E511, 2018 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30079472
15.
First-in-Man Experience with a Novel Catheter-Based Renal Denervation System of Ultrasonic Ablation in Patients with Resistant Hypertension.
J Vasc Interv Radiol
; 29(8): 1158-1166, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29921526
16.
Reply to the letter regarding: "Incomplete coronary sinus reducer endothelialisation as potential mechanism of clinical failure".
Catheter Cardiovasc Interv
; 96(4): E495, 2020 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31364791
17.
Bioabsorbable polymer-coated sirolimus-eluting stent implantation preserves coronary vasomotion: A DESSOLVE II trial sub-study.
Catheter Cardiovasc Interv
; 86(7): 1141-50, 2015 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25044635
18.
Safety and performance of the drug-eluting absorbable metal scaffold (DREAMS) in patients with de-novo coronary lesions: 12 month results of the prospective, multicentre, first-in-man BIOSOLVE-I trial.
Lancet
; 381(9869): 836-44, 2013 Mar 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-23332165
19.
Baseline and 9 months IVUS analysis of the bifurcation-dedicated biolimus A9-eluting Axxess stent system: the DIVERGE IVUS substudy.
Catheter Cardiovasc Interv
; 84(7): 1062-70, 2014 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24478226
20.
Intravascular ultrasound analysis of small vessel lesions treated with the Sparrow coronary stent system: results of the CARE II trial.
Catheter Cardiovasc Interv
; 83(1): 19-24, 2014 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23413202